Find below videos and webinars on myeloma. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
MPE Webinar | EHA 2025 highlights

Now Playing
MPE Webinar | EHA 2025 highlights
Recording of the webinar organised to summarise the most important ...
Recording of the webinar organised to summarise the most important myeloma updates presented at the European Hematology Association (EHA) Annual Congress 2025, held in Milan, Italy.

Now Playing
EHA 2025 | Shared Decision-Making (SMD)
The MPE Head of Patient Research, Eilidh Duncan, presented the results ...
The MPE Head of Patient Research, Eilidh Duncan, presented the results of our Shared Decision-Making (SMD) research. In this video interview, Eilidh explains the key aspects, challenges and recommendations of ...this concept.Show More

Now Playing
EHA 2025 | IRAKLIA study
Prof. Xavier Leleu shares results from the phase 3 IRAKLIA study of ...
Prof. Xavier Leleu shares results from the phase 3 IRAKLIA study of isatuximab subcutaneous via an on-body delivery system versus isatuximab intravenous, plus pomalidomide and dexamethasone, for relapsed/refractory myeloma patients.
For ...more information, visit http://www.mpeurope.orgShow More
For ...more information, visit http://www.mpeurope.orgShow More

Now Playing
EHA 2025 | GMMG CONCEPT trial
MPE interviewed Dr. Lisa Leypoldt about the results of transplant ...
MPE interviewed Dr. Lisa Leypoldt about the results of transplant ineligible patients from the GMMG-CONCEPT trial looking at isatuximab, carfilzomib, lenalidomide, and dexamethasone (ISA-KRD) for high-risk newly diagnosed myeloma patients. ...This clinical trial was presented at the European Hematology Association (EHA) Annual Congress, held in Milan, Italy.Show More

Now Playing
EHA 2025 | GIMEMA CLARITY study
Myeloma Patients Europe (MPE) interviewed Francesco Sparano from ...
Myeloma Patients Europe (MPE) interviewed Francesco Sparano from Fondazione GIMEMA Franco Mandelli onlus on results from the GIMEMA-CLARITY study on the link between quality of life and socio-economic status of ...myeloma patients in Italy and the UK. The study was presented at the Euroepan Hematology (EHA) Annual Congress 2025, held in Milan, Italy.Show More

Now Playing
EHA 2025 | CARTITUDE-1
Dr. Sundar Jagannath, from the Icahn School of Medicine at Mount Sinai ...
Dr. Sundar Jagannath, from the Icahn School of Medicine at Mount Sinai in New York, USA, explains in a very simple way the important results of the CARTITUDE-1 clinical trial, ...presented at the European Hematology Association (EHA) Annual Congress 2025, held in Milan, Italy. Dr. Jagannath also explains key aspects of CARTITUDE-4, CARTITUDE-5 and CARTITUDE-6.
For more information, visit http://www.mpeurope.org.Show More
For more information, visit http://www.mpeurope.org.Show More

Now Playing
EHA 2025 | PREDATOR MRD clinical trial
Video interview with Dr. Krzysztof Giannopoulos, Medical University of ...
Video interview with Dr. Krzysztof Giannopoulos, Medical University of Lublin, Poland, summarising the main results of the clinical trial PREDADOR-MRD.
For more information, visit http://www.mpeurope.org
For more information, visit http://www.mpeurope.org

Now Playing
EHA 2025 | RedirecTT 1 clinical trial
Video-interview with Dr. Shaji Kumar about the RedirecTT-1 clinical ...
Video-interview with Dr. Shaji Kumar about the RedirecTT-1 clinical trial which evaluates talquetamab plus teclistamab in relapsed or refractory myeloma. These results were presented at the European Hematology Association Annual ...Congress 2025, in Milán, Italy.Show More

Now Playing
EHA 2025 | JNJ-5322, a novel, next generation-trispecific antibody
Video interview with Monique Minemma from the University Medical ...
Video interview with Monique Minemma from the University Medical Centre Utrecht, summarising for MPE the main results of the clinical trial of JNJ-5322, a novel next-generation trispecific antibody, presented at ...the European Hematology Association (EHA) 2025 Congress in Milan, Italy. For more information, visit http://www.mpeurope.org.Show More

Now Playing
EHA 2025 | High risk myeloma
Video interview with Dr. Martin Kaiser, Royal Marsden Hospital, ...
Video interview with Dr. Martin Kaiser, Royal Marsden Hospital, London, UK, on clinical approach to high risk myeloma, during the European Hematology Association (EHA) Annual Congress, held in Milan, Italy, ...from 12 to 15 June 2025.
Visit http://www.mpeurope.org for more informationShow More
Visit http://www.mpeurope.org for more informationShow More

Now Playing
Masterclass 2025 | Early diagnosis challenges
Video interview with Prof. Dr. Irit Avivi, Director of the Haematology ...
Video interview with Prof. Dr. Irit Avivi, Director of the Haematology Department at TASMC – Tel Aviv Sourasky Medical Centre – summarising her talk on early diagnosis challenges, given at ...the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More

Now Playing
Masterclass 2025 | Care for carers
Prabneet Parmar, Support Group Coordinator at Myeloma UK, an MPE ...
Prabneet Parmar, Support Group Coordinator at Myeloma UK, an MPE member organisation, talks about carers' needs and how patient organisations can address them.

Now Playing
MPE Masterclass 2025 | Sequencing of myeloma treatment
Video interview filmed with Dr. Dominik Dytfeld about the talk ...
Video interview filmed with Dr. Dominik Dytfeld about the talk "Sequencing of myeloma treatment", given in the MPE Masterclass 2025, held in Warsaw, Polan, from 2-4 May.

Now Playing
MPE Masterclass 2025 | Use of AI in patient care and treatment
Adam Radziszewski, Lead Applied Scientist at Infermedica, responds our ...
Adam Radziszewski, Lead Applied Scientist at Infermedica, responds our questions about the use of Artificial Intelligence (AI) in patient care and treatment.
This recording summarises the key points from Adam’s ...talk at the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More
This recording summarises the key points from Adam’s ...talk at the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More

Now Playing
Ask the Expert Q&A | Living well with myeloma
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds ...
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds patients' questions about living well with myeloma. This Q&A was organised by Myeloma Patients Europe (MPE) on the occasion of the Myeloma ...Awareness Month 2025.Show More
1
of 10